These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Lesauskaite V, Epistolato MC, Castagnini M, Urbonavicius S, Tanganelli P. Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871 [Abstract] [Full Text] [Related]
6. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Wilson WR, Anderton M, Schwalbe EC, Jones JL, Furness PN, Bell PR, Thompson MM. Circulation; 2006 Jan 24; 113(3):438-45. PubMed ID: 16432074 [Abstract] [Full Text] [Related]
10. Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm. Kazi M, Zhu C, Roy J, Paulsson-Berne G, Hamsten A, Swedenborg J, Hedin U, Eriksson P. Arterioscler Thromb Vasc Biol; 2005 Jul 24; 25(7):1341-6. PubMed ID: 15845912 [Abstract] [Full Text] [Related]
14. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease. De S, Fenton JE, Jones AS. J Laryngol Otol; 2005 Jun 24; 119(6):436-42. PubMed ID: 15992468 [Abstract] [Full Text] [Related]